Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow Quality Index
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥69.15 Million exceeds net income of CN¥24.01 Million, indicating high earnings quality where cash backs reported profits. Explore Anhui Fengyuan Pharmaceutical Co Ltd (000153) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Anhui Fengyuan Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Anhui Fengyuan Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Anhui Fengyuan Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.20x | CN¥119.30 Million | CN¥99.42 Million | ▲ +49.9% |
| 2024 | 0.80x | CN¥126.24 Million | CN¥157.65 Million | ▼ -50.6% |
| 2023 | 1.62x | CN¥254.75 Million | CN¥157.30 Million | ▼ -44.4% |
| 2022 | 2.91x | CN¥439.99 Million | CN¥150.94 Million | ▲ +34.1% |
| 2021 | 2.17x | CN¥237.88 Million | CN¥109.47 Million | ▼ -24.2% |
| 2020 | 2.87x | CN¥292.75 Million | CN¥102.10 Million | ▲ +249.1% |
| 2019 | 0.82x | CN¥66.21 Million | CN¥80.61 Million | ▼ -78.7% |
| 2018 | 3.85x | CN¥233.59 Million | CN¥60.71 Million | ▲ +379.9% |
| 2017 | 0.80x | CN¥52.40 Million | CN¥65.35 Million | ▼ -53.1% |
| 2016 | 1.71x | CN¥78.21 Million | CN¥45.71 Million | ▲ +18.3% |
| 2015 | 1.45x | CN¥45.50 Million | CN¥31.47 Million | ▲ +465.6% |
| 2014 | 0.26x | CN¥10.51 Million | CN¥41.12 Million | ▲ +109.9% |
| 2013 | -2.59x | CN¥-70.31 Million | CN¥27.19 Million | ▼ -202.5% |
| 2012 | 2.52x | CN¥45.65 Million | CN¥18.09 Million | ▼ -54.5% |
| 2011 | 5.55x | CN¥55.06 Million | CN¥9.92 Million | ▲ +308.1% |
| 2010 | 1.36x | CN¥55.04 Million | CN¥40.48 Million | ▼ -0.5% |
| 2009 | 1.37x | CN¥32.41 Million | CN¥23.71 Million | ▼ -58.3% |
| 2008 | 3.28x | CN¥49.82 Million | CN¥15.20 Million | ▼ -65.1% |
| 2007 | 9.38x | CN¥55.26 Million | CN¥5.89 Million | ▲ +473.0% |
| 2006 | 1.64x | CN¥36.27 Million | CN¥22.15 Million | ▼ -56.4% |
| 2005 | 3.76x | CN¥34.88 Million | CN¥9.28 Million | ▲ +422.3% |
| 2004 | -1.17x | CN¥-11.72 Million | CN¥10.04 Million | ▼ -84.5% |
| 2003 | -0.63x | CN¥-11.46 Million | CN¥18.12 Million | ▼ -255.9% |
| 2002 | 0.41x | CN¥10.48 Million | CN¥25.82 Million | ▼ -57.4% |
| 2001 | 0.95x | CN¥23.57 Million | CN¥24.77 Million | ▼ -3.4% |
| 2000 | 0.99x | CN¥25.88 Million | CN¥26.27 Million | ▲ +739.6% |
| 1999 | 0.12x | CN¥1.01 Million | CN¥8.64 Million | — |